Brief: Rua Bioscience Says HY Operating Loss NZ$3.48 Million
Feb 26 (Reuters) - Rua Bioscience Ltd RUA.NZ :
* HY OPERATING LOSS NZ$3.48 MILLION
* HOPE TO ACHIEVE CERTIFICATION BY MID/LATE APRIL FOR
GISBORNE
MANUFACTURING FACILITY
* CERTIFICATION DELAY AT GISBORNE FACILITY UNLIKELY TO HIT
1ST
COMMERCIAL PRODUCTION IN LATE H1, 1ST DRIED FLOWER EXPORT
REVENUE BY H2-END
Source text for Eikon: ID:nNZW8pwbXr
Further company coverage: RUA.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth